Search

Enhancing Utility of Neuropsychological Evaluation for Earlier and Effective Diagnosis of Dementia in Parkinson's Disease

Trial N/A Not yet recruiting Aug. 10, 2025

Cognitive Training in Parkinson's Disease

Trial N/A Completed Aug. 10, 2025

A Study Comparing Propranolol and Amantadine for Reducing Tremors in People With Parkinson's Disease

Trial N/A Completed Aug. 7, 2025

Impact of a Biophoton Therapy on Patients With Brain Disorders

Trial N/A Recruiting Aug. 7, 2025

Can regulators have a role in facilitating the development of new medicines for Parkinson's disease?

News SAGE Publications: Journal of Parkinson’s Disease: Table of Contents Aug. 7, 2025

Training of Nursing Home Professionals and Quality of Life of Residents With Parkinson's Disease

Trial N/A Recruiting Aug. 6, 2025

The Effects of fNIRS-based Neurofeedback Training on Balance and Gait in Parkinson's Disease

Trial N/A Recruiting Aug. 6, 2025

Saliva and Extracellular Vesicles for Neurodegenerative Diseases

Trial N/A Recruiting Aug. 6, 2025

Adhesion and Safety of Rotigexole Compared to Neupro®

Trial N/A Not yet recruiting Aug. 6, 2025

Steps Against the Burden of Parkinson's Disease - TelAviv/Bologna

Trial N/A Recruiting Aug. 5, 2025

Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy

Trial Phase 2 Terminated Aug. 5, 2025

Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy

Trial Phase 2 Terminated Aug. 5, 2025

Quantitation of Glymphatic Functioning in Sleep and Meditative States

Trial N/A Completed Aug. 5, 2025

CUE1+ device improves motor and non-motor outcomes in Parkinson’s disease: Findings from a QMUL double-blind, sham-controlled, randomised study

News Charco Neurotech Aug. 5, 2025

Study on Practical ExperienceS of Treatment With Foslevodopa/foScaRbidopa in Advanced Parkinson's Disease

Trial N/A Recruiting Aug. 4, 2025

Quantification Tools for a Novel Tau PET Marker in a Rare Neurological Disease: 18F-PI-2620 in Progressive Supranuclear Palsy

Trial Phase 2 Active, not recruiting Aug. 4, 2025

Meridian Activation Remedy System for Parkinson's Disease

Trial N/A Completed Aug. 4, 2025

Pilot Trial Evaluating Patient Experience With the MemorEM for Patients With Neurological Diseases

Trial N/A Enrolling by invitation Aug. 4, 2025

Gait and Balance Impairment in Rare and Very Rare Neurological Diseases

Trial N/A Recruiting Aug. 2, 2025

Evaluation of GM101 Injection in Patients With Parkinson's Disease

Trial Early Phase 1 Recruiting Aug. 2, 2025